Loading...
Loading...
AMERICAN SHARED HOSPITAL SERVICES
AMS today provided an update on its previously Board authorized 1,000,000 share repurchase program.
AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D., said, "In view of the exciting recent news regarding FDA 510(k) clearance for the MEVION S250 proton therapy device, which we believe has not been properly reflected in our share price, we have decided to re-activate our share repurchase program. We are prepared to commence buying back our shares, if the price remains near the current market price." The Company has repurchased approximately 919,000 shares of AMS common stock under the stock repurchase authorization, and currently has approximately 4,600,000 common shares outstanding.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in